CareDx CDNA
NASDAQ CDNA
$67.08 +3.08 (+4.81%)
At close: Oct 19, 2026 · 4:00 PM EDT

CareDx (CDNA) Gains from Sales and Divestitures (2023 - 2026)

Updated

CareDx (CDNA) recorded Gains from Sales and Divestitures of $113.09 million in Q2 2026.

Analysis

CareDx (CDNA) Gains from Sales and Divestitures (2023 - 2026) Analysis & Trends

On a TTM basis, CareDx's Gains from Sales and Divestitures came in at $112.97 million as of Jun 30, 2026; for FY2025, it was -$48,000.

  • Across earlier years, Gains from Sales and Divestitures came in at -$91,000 in FY2024 and -$44,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 100.51 Bn 96.52 Bn -
2 Natera 57.27 Bn 52.95 Bn 485.19 Mn
3 Quest Diagnostics 26.09 Bn 24.22 Bn 1.03 Bn
4 Labcorp Holdings 26.08 Bn 23.83 Bn 1.11 Bn
5 Tenet Healthcare 22.29 Bn 11.30 Bn -
6 Guardant Health 21.03 Bn 17.09 Bn 219.03 Mn
7 Fresenius Medical Care AG 12.78 Bn 4.73 Bn 1.52 Bn
8 BrightSpring Health Services 12.65 Bn 10.98 Bn 492.75 Mn
9 Davita 12.13 Bn 9.34 Bn 1.16 Bn
10 CareDx 3.45 Bn 2.52 Bn 96.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 113.09 Mn
Mar 31, 2026 -119,000.00
Dec 31, 2024 -91,000.00
Dec 31, 2023 -7,000.00
API Access

CareDx Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=CDNA&period=max&api_key=YOUR_API_KEY